title: Ceramide alters endothelial cell permeability by a nonapoptotic mechanism.
abstract: Ceramide is a lipid second messenger that was recently identified as mediator of pulmonary edema in vivo. Here, we investigated the effect of ceramide on the permeability of confluent endothelial cell monolayers. In monolayers of bovine pulmonary artery and human microvascular pulmonary endothelial cells, incubation with C6-ceramide for 3 h elevated permeability in a concentration-dependent manner, whereas dihydroceramide was without effect. After 3 h of incubation with ceramide, we found no signs of necrosis (release of lactate dehydrogenase, loss of thiazylyl blue reduction) or apoptosis (ssDNA, caspase-8 activity). The increased endothelial permeability in response to ceramide was attenuated by the Ser/Thr protein kinase inhibitors K252a, K252b and H-7, as well as by the phosphatidylinositol-specific phospholipase C inhibitor L108. Since in some systems sphingosine-1-phosphate (S1P) acts antagonistic to ceramide, the effect of S1P was studied. S1P transiently increased endothelial cell resistance, whether it was given together with ceramide or 90 min thereafter. These data provide a novel example of the antagonism between S1P and ceramide. Our findings further suggest that ceramide alters vascular permeability by activation of pathways dependent on unidentified phospholipase C and Ser/Thr kinase isoenzymes.
authors.affiliation: Division Pulmonary Pharmacology, Research Center Borstel, Parkallee 22, Borstel D-23845, Germany.
authors.forename: Karsten
authors.initials: K
authors.lastname: Lindner
authors.forename: Ulrike
authors.initials: U
authors.lastname: Uhlig
authors.forename: Stefan
authors.initials: S
authors.lastname: Uhlig
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D002417:Cattle; D002463:Cell Membrane Permeability / Q000502:physiology*; D002478:Cells, Cultured; D002518:Ceramides / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D042783:Endothelial Cells / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D004730:Endothelium, Vascular / Q000166:cytology / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D008246:Lysophospholipids / Q000502:physiology; D009336:Necrosis; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000502:physiology
chemical_list: D002518:Ceramides; D004791:Enzyme Inhibitors; D008246:Lysophospholipids; C101954:N-caproylsphingosine; C060506:sphingosine 1-phosphate; D013110:Sphingosine
references.citation: J Biol Chem. 2003 Nov 21;278(47):47281-90
references.pmid: 12954648
references.citation: J Nutr. 2003 Nov;133(11):3343-9
references.pmid: 14608042
references.citation: Blood. 1983 Sep;62(3):549-56
references.pmid: 6309278
references.citation: Nature. 1983 Nov 3-9;306(5938):67-9
references.pmid: 6605482
references.citation: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references.pmid: 6606682
references.citation: Biochemistry. 1984 Oct 9;23(21):5036-41
references.pmid: 6238627
references.citation: J Cell Physiol. 1986 Jul;128(1):96-104
references.pmid: 3722274
references.citation: Biochem Biophys Res Commun. 1987 Jan 30;142(2):436-40
references.pmid: 3028414
references.citation: Biochem Biophys Res Commun. 1987 Apr 14;144(1):35-40
references.pmid: 3579911
references.citation: J Biol Chem. 1987 Jun 5;262(16):7796-801
references.pmid: 3108259
references.citation: Am J Physiol. 1989 Sep;257(3 Pt 1):C562-7
references.pmid: 2782396
references.citation: Biochem Biophys Res Commun. 1991 Nov 27;181(1):423-9
references.pmid: 1659814
references.citation: Cancer Res. 1992 May 15;52(10):2835-40
references.pmid: 1316230
references.citation: J Biotechnol. 1992 Sep;25(3):231-43
references.pmid: 1368802
references.citation: Arterioscler Thromb Vasc Biol. 1996 Mar;16(3):488-96
references.pmid: 8630677
references.citation: Circ Res. 1996 Oct;79(4):736-47
references.pmid: 8831497
references.citation: J Exp Med. 1997 Dec 1;186(11):1831-41
references.pmid: 9382882
references.citation: J Biol Chem. 1998 Oct 16;273(42):27389-95
references.pmid: 9765267
references.citation: Cell Struct Funct. 1998 Oct;23(5):255-64
references.pmid: 9872566
references.citation: Am J Physiol. 1999 Mar;276(3 Pt 1):L481-90
references.pmid: 10070113
references.citation: J Biol Chem. 1999 May 7;274(19):13643-9
references.pmid: 10224136
references.citation: Blood. 1999 Jun 15;93(12):4293-9
references.pmid: 10361127
references.citation: Endocrinology. 2005 Mar;146(3):1312-20
references.pmid: 15591142
references.citation: Biochim Biophys Acta. 2000 May 31;1485(2-3):63-99
references.pmid: 10832090
references.citation: Am J Physiol Lung Cell Mol Physiol. 2001 Jun;280(6):L1168-78
references.pmid: 11350795
references.citation: J Immunol Methods. 2001 Jul 1;253(1-2):133-44
references.pmid: 11384675
references.citation: J Clin Invest. 2001 Sep;108(5):689-701
references.pmid: 11544274
references.citation: Am J Physiol Lung Cell Mol Physiol. 2001 Oct;281(4):L958-68
references.pmid: 11557600
references.citation: J Appl Physiol (1985). 2001 Oct;91(4):1487-500
references.pmid: 11568129
references.citation: J Cell Sci. 2002 Jun 15;115(Pt 12):2475-84
references.pmid: 12045218
references.citation: J Clin Invest. 2002 Jul;110(1):3-8
references.pmid: 12093880
references.citation: J Biol Chem. 2002 Aug 23;277(34):30469-76
references.pmid: 12063265
references.citation: Biochem Biophys Res Commun. 2003 Feb 7;301(2):564-71
references.pmid: 12565900
references.citation: Biochem J. 2003 Apr 1;371(Pt 1):199-204
references.pmid: 12534346
references.citation: Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L258-67
references.pmid: 12626332
references.citation: Oncogene. 2003 Sep 1;22(37):5897-906
references.pmid: 12947396
references.citation: Nat Med. 2004 Feb;10(2):155-60
references.pmid: 14704790